Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07254650Not ApplicableNot Yet Recruiting

Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1

Role: collaborator

NCT03671304Not ApplicableTerminated

Mobile Intervention - Physical Activity in Cancer Treatment

Role: collaborator

NCT02427100Not ApplicableCompleted

Evaluation of a Shelter-Based Diet and Physical Activity Intervention for Homeless Adults

Role: collaborator

NCT00628732Phase 2Completed

A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors

Role: collaborator

All 4 trials loaded